Page last updated: 2024-08-21

perfluorobutane and iopamidol

perfluorobutane has been researched along with iopamidol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuda, H; Kondo, M; Maeda, S; Morimoto, M; Nozaki, A; Numata, K; Okada, M; Oshima, T; Takebayashi, S; Tanaka, K	1

Trials

1 trial(s) available for perfluorobutane and iopamidol

Article	Year
Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. European journal of radiology, 2012, Volume: 81, Issue:10 Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Fluorocarbons; Humans; Iopamidol; Liver Neoplasms; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography	2012

Article

Year

Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.

European journal of radiology, 2012, Volume: 81, Issue:10

Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Fluorocarbons; Humans; Iopamidol; Liver Neoplasms; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography

2012